Plume Clinic.

There is a familiar way that healthcare startups pitch themselves, and it usually involves the word "friction." Booking is frictionless, prescriptions are frictionless, the app is frictionless. Plume Clinic, founded in Denver in 2019, uses that language too. But the friction Plume set out to remove was not a scheduling inconvenience. It was the fact that, for a huge share of transgender Americans, gender-affirming care was somewhere between hard to find, expensive, geographically impossible, or gated behind a therapist's letter and a skeptical provider. That is a different kind of friction. It is the kind that makes people give up.

The company's answer was almost aggressively simple: put a licensed clinician on a video call, use an informed-consent model so patients do not need a therapist's permission slip, prescribe hormone therapy - estrogen, testosterone, blockers - order the labs, monitor the results, and write the letters people need for surgery or to change the gender marker on a driver's license. Bundle it into a membership. Make it work from a phone in all but a couple of states. None of these are technological breakthroughs. The breakthrough, such as it is, was deciding that trans people were a population worth building a whole company around, and then actually building it.

What makes the story more than a business-model anecdote is who did the building. Plume was co-founded by two physicians, Dr. Jerrica Kirkley and Dr. Matthew Wetschler, who met on their first day of medical school and stayed close for about fifteen years before starting the company. Kirkley, who serves as Chief Medical Officer, is a trans woman - which means she is both the doctor designing the care and, in a real sense, the patient it is designed for. In most startups that dual perspective would be a nice line in the founding deck. At Plume it functions closer to a product spec.

The staffing choices follow the same logic. More than 70% of the organization identifies as transgender or gender non-conforming - and, notably, that is not confined to the clinical team. More than half of the business side is trans too. It is easy to file this under "representation" and move on, but it does real work: when the people writing the intake flow, the support scripts, and the marketing copy share the identity of the patients, the empathy gap that plagues most healthcare products largely closes on its own.

Mission-driven healthcare has a recurring plot twist: the model that keeps the doors open is not always the model patients want. In 2025 Plume announced it would end insurance-based memberships on December 31 of that year, moving members onto a self-pay plan effective January 1, 2026. For patients who had been using insurance, that is a real cost change, and the kind of decision a company only makes when the economics of billing payers stop working. It is worth naming plainly rather than dressing up - running a specialized virtual clinic on payer contracts is hard, and Plume chose predictability over a coverage model it could not sustain.

Set against that is the softer, arguably more durable move: the Community Hub, launched in 2024 for the company's fifth anniversary, which added trans-led support groups and workshops alongside the clinical product. It reflects a thesis Plume has held from the start - that isolation is a health issue, and that a clinic for trans people is also, usefully, a place to be seen.